(Q39137284)

9 September 2017

title

Neural stem cell-based gene therapy for brain tumors (English)

1 reference

9 September 2017

0 references

1 reference

Seung U Kim

1

1 reference

9 September 2017

publication date

1 March 2011

1 reference

Stem Cell Reviews and Reports

9 September 2017

published in

1 reference

9 September 2017

volume

7

1 reference

9 September 2017

issue

1

1 reference

9 September 2017

page(s)

130-140

1 reference

Medulloblastoma: clinical and biologic aspects

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Gene therapy clinical trials worldwide to 2007--an update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Control of oncogene expression by antisense nucleic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Induction of the interferon response by siRNA is cell type- and duplex length-dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Metabolic suicide genes in gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

p53-dependent apoptosis pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Apoptotic genes in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Phase 1 and pharmacodynamic studies of G3139, a Bcl-2 antisense oligonucleotide, in combination with chemotherapy in refractory or relapsed acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Control of gene expression by triple helix-forming oligonucleotides. The antigene strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Combination antigene therapy targeting c-myc and c-erbB(2) in the ovarian cancer COC(1) cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Gene therapy for colon cancer with the herpes simplex thymidine kinase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Suicide gene therapy mediated by the Herpes Simplex virus thymidine kinase gene/Ganciclovir system: fifteen years of application.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Gene therapy of orthotopic hepatocellular carcinoma in rats using adenovirus coding for interleukin 12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Gene transfer of CD154 and IL12 cDNA induces an anti-leukemic immunity in a murine model of acute leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Genetic immunotherapy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Mouse alpha-fetoprotein-specific DNA-based immunotherapy of hepatocellular carcinoma leads to tumor regression in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

DNA vaccination with AFP-encoding plasmid DNA prevents growth of subcutaneous AFP-expressing tumors and does not interfere with liver regeneration in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Neuronal progenitors as tools for cell replacement in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Engraftable human neural stem cells respond to developmental cues, replace neurons, and express foreign genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Human neural stem cells genetically modified for brain repair in neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Stem cell therapy for human neurodegenerative disorders-how to make it work

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Stem and progenitor cell-based therapy of the human central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Gene therapy: can neural stem cells deliver?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Stem cells act through multiple mechanisms to benefit mice with neurodegenerative metabolic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Stem cell-based cell therapy in neurological diseases: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Targeting of melanoma brain metastases using engineered neural stem/progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Intravascular delivery of neural stem cell lines to target intracranial and extracranial tumors of neural and non-neural origin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Novel method for visualizing and modeling the spatial distribution of neural stem cells within intracranial glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Tumor-targeted enzyme/prodrug therapy mediates long-term disease-free survival of mice bearing disseminated neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Human neural stem cells target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Human neural stem cells target and deliver therapeutic gene to experimental leptomeningeal medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Brain transplantation of human neural stem cells transduced with tyrosine hydroxylase and GTP cyclohydrolase 1 provides functional improvement in animal models of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Transplantation of human neural stem cells exerts neuroprotection in a rat model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Proactive transplantation of human neural stem cells prevents degeneration of striatal neurons in a rat model of Huntington disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Intravenous administration of human neural stem cells induces functional recovery in Huntington's disease rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Intrathecal transplantation of human neural stem cells overexpressing VEGF provide behavioral improvement, disease onset delay and survival extension in transgenic ALS mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Human neural stem cell transplantation promotes functional recovery in rats with experimental intracerebral hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Combined treatment of vascular endothelial growth factor and human neural stem cells in experimental focal cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Identification of CXCR4 as a new nitric oxide-regulated gene in human CD34+ cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Human neural stem cells over-expressing VEGF provide neuroprotection, angiogenesis and functional recovery in mouse stroke model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Human neural stem cells overexpressing glial cell line-derived neurotrophic factor in experimental cerebral hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Brain transplantation of genetically engineered human neural stem cells globally corrects brain lesions in the mucopolysaccharidosis type VII mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Stem cell factor is a chemoattractant and a survival factor for CNS stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Neuronally expressed stem cell factor induces neural stem cell migration to areas of brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

MCP-1 induces migration of adult neural stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Intravenously transplanted human neural stem cells migrate to the injured spinal cord in adult mice in an SDF-1- and HGF-dependent manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Brain tumor tropism of transplanted human neural stem cells is induced by vascular endothelial growth factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Constitutive EGFR signaling confers a motile phenotype to neural stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Neural stem cell targeting of glioma is dependent on phosphoinositide 3-kinase signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Urokinase plasminogen activator and urokinase plasminogen activator receptor mediate human stem cell tropism to malignant solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Neural stem cell tropism to glioma: critical role of tumor hypoxia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Hepatocyte growth factor effects on mesenchymal stem cells: proliferation, migration, and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Migration of endothelial progenitor cells mediated by stromal cell-derived factor-1alpha/CXCR4 via PI3K/Akt/eNOS signal transduction pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Iron labeling and pre-clinical MRI visualization of therapeutic human neural stem cells in a murine glioma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Transplantation of prodrug-converting neural progenitor cells for brain tumor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Neural precursor cells for delivery of replication-conditional HSV-1 vectors to intracerebral gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Bystander effect-mediated gene therapy of gliomas using genetically engineered neural stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

PEX-producing human neural stem cells inhibit tumor growth in a mouse glioma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Human neural stem cells can target and deliver therapeutic genes to breast cancer brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Human glioma-derived interleukin-10 inhibits antitumor immune responses in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Interleukin-12-based immunotherapy against rat 9L glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

In situ adenoviral interleukin 12 gene transfer confers potent and long-lasting cytotoxic immunity in glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Gene therapy of experimental brain tumors using neural progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

APO2 ligand: a novel lethal weapon against malignant glioma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

The biochemistry of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Therapeutic stem-cells for cancer treatment: hopes and hurdles in tactical warfare

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Inducible release of TRAIL fusion proteins from a proapoptotic form for tumor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Glioma therapy and real-time imaging of neural precursor cell migration and tumor regression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

In vivo tracking of neural progenitor cell migration to glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

How cells respond to interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Antitumor efficacy of AAV-mediated systemic delivery of interferon-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Interferon-alpha in tumor immunity and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Microvascular injury in pathogenesis of interferon-induced necrosis of subcutaneous tumors in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Interferon-beta gene therapy for cancer: basic research to clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Intravascular administration of tumor tropic neural progenitor cells permits targeted delivery of interferon-beta and restricts tumor growth in a murine model of disseminated neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Targeting rat brainstem glioma using human neural stem cells and human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

c-MycERTAM transgene silencing in a genetically modified human neural stem cell line implanted into MCAo rodent brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Gene therapy and targeted toxins for glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Production and characterization of immortal human neural stem cell line with multipotent differentiation property

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Neural Cell Adhesion Molecule Polysialylation Enhances the Sensitivity of Embryonic Stem Cell-Derived Neural Precursors to Migration Guidance Cues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Two-dimensional ferroelectric films

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-010-9154-1

Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis

21 January 2018

1 reference

12 December 2020

The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified.

1 reference

12 December 2020

Alpha-fetoprotein-specific genetic immunotherapy for hepatocellular carcinoma

1 reference

12 December 2020

The c-myc story: where we've been, where we seem to be going.

1 reference

12 December 2020

Herpes simplex virus thymidine kinase/ganciclovir-mediated apoptotic death of bystander cells.

1 reference

12 December 2020

1 reference

12 December 2020

Direct stimulation of apoptotic signaling by soluble Apo2l/tumor necrosis factor-related apoptosis-inducing ligand leads to selective killing of glioma cells.

1 reference

12 December 2020

Induction of p53-regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 (INGN 201) and radiation therapy.

1 reference

12 December 2020

Eradication of rat malignant gliomas by retroviral-mediated, in vivo delivery of the interleukin 4 gene.

1 reference

12 December 2020

Intratumoral injection of interleukin-12 plasmid DNA, either naked or in complex with cationic lipid, results in similar tumor regression in a murine model.

1 reference

12 December 2020

Human neurological cancer cells express interleukin-4 (IL-4) receptors which are targets for the toxic effects of IL4-Pseudomonas exotoxin chimeric protein

1 reference

12 December 2020

Development of a tumor-selective approach to treat metastatic cancer

1 reference

12 December 2020

Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors

1 reference

12 December 2020

Overexpression of a rabbit liver carboxylesterase sensitizes human tumor cells to CPT-11

1 reference

12 December 2020

Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer

1 reference

12 December 2020

The use of interleukin 12-secreting neural stem cells for the treatment of intracranial glioma

1 reference

12 December 2020

Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer

1 reference

12 December 2020

Therapeutic targeting of melanoma cells using neural stem cells expressing carboxylesterase, a CPT-11 activating enzyme

1 reference

12 December 2020

Human neural stem cells transduced with IFN-beta and cytosine deaminase genes intensify bystander effect in experimental glioma

1 reference

12 December 2020

Enzyme/prodrug gene therapy approach for breast cancer using a recombinant adenovirus expressing Escherichia coli cytosine deaminase.

1 reference

12 December 2020

Brain transplantation of immortalized human neural stem cells promotes functional recovery in mouse intracerebral hemorrhage stroke model

1 reference

12 December 2020

In vivo growth inhibitory effect of iterative wild-type p53 gene transfer in human head and neck carcinoma xenografts using glucosylated polyethylenimine nonviral vector

1 reference

12 December 2020

Human neural stem cells can migrate, differentiate, and integrate after intravenous transplantation in adult rats with transient forebrain ischemia

1 reference

12 December 2020

Diffusible cytotoxic metabolites contribute to the in vitro bystander effect associated with the cyclophosphamide/cytochrome P450 2B1 cancer gene therapy paradigm.

1 reference

12 December 2020

Descriptive epidemiology of primary brain and CNS tumors: results from the Central Brain Tumor Registry of the United States, 1990-1994

1 reference

12 December 2020

Gene-directed enzyme prodrug therapy with a mustard prodrug/carboxypeptidase G2 combination

1 reference

12 December 2020

Cellular and genetic characterization of human adult bone marrow-derived neural stem-like cells: a potential antiglioma cellular vector

1 reference

12 December 2020

Simultaneous inhibition of glioma angiogenesis, cell proliferation, and invasion by a naturally occurring fragment of human metalloproteinase-2.

1 reference

12 December 2020

Induction of glioblastoma apoptosis using neural stem cell-mediated delivery of tumor necrosis factor-related apoptosis-inducing ligand

1 reference

12 December 2020

Inhibition of ras oncogene: a novel approach to antineoplastic therapy

1 reference

12 December 2020

Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production

1 reference

12 December 2020

Neural stem cells as a novel platform for tumor-specific delivery of therapeutic antibodies

1 reference

12 December 2020

The failure of current immunotherapy for malignant glioma. Tumor-derived TGF-beta, T-cell apoptosis, and the immune privilege of the brain

1 reference

12 December 2020

Anti-inflammatory mechanism of intravascular neural stem cell transplantation in haemorrhagic stroke

1 reference

12 December 2020

p53 gene therapy in a rat model of hepatocellular carcinoma: intra-arterial delivery of a recombinant adenovirus.

1 reference

12 December 2020

10.1007/S12015-010-9154-1

Identifiers

DOI

1 reference

9 September 2017

1 reference